Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2025;15(2): 371-389. doi: 10.34172/apb.025.43681
PMID: 40922742        PMCID: PMC12413968

Original Article

Codelivery of Raloxifene and Rutin as PEGylated Nanoliposomes: Formulation, Characterization, and Prophylactic Activity Against Breast Cancer

Maryam Abdulmaged Oleiwi 1 ORCID, Ali Al-Samydai 1 * ORCID, Aya Y. Al-Kabariti 2 ORCID, Khaldun M. Al Azzam 3 ORCID, Simone Carradori 4 ORCID, Walhan Alshaer 5 ORCID

Cited by CrossRef:

1- Regulagadda S, Geddam R, Vasa T, Rudhrabatla V, Gode T, Padigapati S. Fabrication of Peptide Drug Delivery Formulations and Its Characterization Techniques: A Review. Int J Pept Res Ther. 2026;32(2) [Crossref]
2- Singh D, Singh A, Singh H. Development and Evaluation of a PEGylated Lyophilized Nanoliposomal Formulation of Nilotinib for Enhanced Solubility, Intestinal Permeation, and In Vitro Anticancer Activity. Asia-Pac J Clncl Oncology. 2026; [Crossref]